GE Healthcare Technologies Inc. is participating in the €25.3 million (US$27.8 million) Thera4care project that aims to expand the use of theranostics in Europe. The 29 partners involved in the project will develop new cancer treatment tools, strengthen the manufacture and supply of radiotheranostic, and optimize the clinical use of radiotheranostics. Read More
A digital cognitive assessment developed by Braincheck Inc., Braincheck Assess, proved comparable to the gold-standard Montreal Cognitive Assessment in identifying patients with cognitive impairment in a study published in Frontiers in Psychology. Read More
It’s hard to know where to start in describing the biopharma applications of the 2024 Nobel Prize in Physics. It was awarded to John Hopfield and Geoffrey Hinton “for foundational discoveries and inventions that enable machine learning with artificial neural networks.” Read More
Certis Oncology Solutions Inc. filed for protection of its artificial intelligence platform that utilizes big data, statistical algorithms, and machine learning to predict drug efficacy based on gene expression biomarkers. Read More
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Braincheck, Brook, Moleculight, Twin Health. Read More
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 4C Medical, Caredx, Caretaker, Cian Diagnostics, Diagnostica Longwood, Emblok, Paradigm Home Health, Patriot Medical, Procept Biorobotics, Vectorcare, Velsera. Read More
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Accukardia, BTL, Healgen, Invivoscribe, Procept Biorobotics, Regenity Biosciences. Read More
